Dr. Smith discusses the most up-to-date information on the use of long-acting injectables for the treatment of psychosis in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Tag: aripiprazole
Optimal Pharmacotherapy for Schizoaffective Disorder
In this lecture, Dr. Dugan discusses medications that might be useful in treating schizoaffective disorder. By the end of this lecture, you will be able to: 1) describe the pharmacotherapeutic medications used for the treatment of schizoaffective disorder (SAD) and 2) compare the efficacy and safety data of different medications for the treatment of patients with SAD.
Addressing Clozapine Associated Sedation
In this lecture, Dr. Dugan looks at the prevalence of clozapine-associated sedation, discusses pharmacological actions of clozapine that may contribute to sedation, and surveys some treatment strategies to reduce or eliminate this side effect. By the end of this lecture, you will be able to: 1) describe the prevalence of clozapine associated sedation, 2) identify pharmacologic actions that may contribute to sedation with clozapine, and 3) evaluate treatment strategies for addressing sedation with clozapine.
Pharmacodynamics: How do antipsychotic medications work?
In this lecture, Dr. Dugan reviews the mechanisms of action of the medications used to treat psychosis. By the end of this lecture, you will be able to: 1) identify common pharmacologic targets of first and second generation antipsychotic medications, 2) describe proposed therapeutic actions of first and second generation antipsychotic medications, and 3) compare adverse effect profiles of the first and second generation antipsychotic medications.
